Siemens Healthcare GmbH
Siemens - Model PFA-100 - Hemostasis System
The PFA-100® System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.
Most popular related searches
hemostasis system
platelet dysfunction
in vitro production
in vitro test
whole blood sample
drug induced
hemostasis
platelet
whole blood
platelet adhesion
The PFA-100 System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.
- Helps detect inherited, acquired and drug-induced platelet dysfunction
- Screening test for patients with impaired primary hemostasis, such as von Willebrand disease1
- Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients2
- Assesses the platelet dysfunction due to the effect of Aspirin
- Evaluates platelet dysfunction in children over 1 year of age3
- Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
The PFA-100 System has become the new standard for detection of platelet dysfunction. The PFA-100 Analyzer quickly and easily measures platelet plug formation in a small, whole blood sample (
A Model of Efficiency:
- Accurate detection of inherited, acquired or induced platelet dysfunction under high-shear stress
- Sensitive to quantitative and qualitative abnormalities of VWD in both plasma and platelets
- Simple, rapid and precise assessment of platelet function
Test Menu:
- Collagen/Epinephrine and Collagen/ADP test cartridges
Features:
- Easy to use - self-contained disposable test cartridges
- Fast - delivers quantitative results within 5 to 8 minutes
- Cost savings - minimal sample manipulation and maintenance required
